What caused the MJRX.CN stock spike on 12 Feb 2026?

The spike to CAD 0.055 was driven by low liquidity and concentrated buying; volume rose to 5,000 shares versus an average of 2,648. There was no major public earnings update, so the move likely reflects order flow and short-term trading dynamics.

What is Meyka AI's view on MJRX.CN stock performance?

Meyka AI gives MJRX.CN a proprietary grade of B+ (score 71.31) and models monthly CAD 0.05 and yearly CAD 0.02837 forecasts. The model implies downside from the current CAD 0.055; forecasts are projections, not guarantees.

Are there price targets for MJRX.CN stock I can use?

Use conservative CAD 0.03, base-case CAD 0.06, and optimistic CAD 0.09 targets. Targets reflect liquidity and the stock’s year high/low range. Position sizing and stop-loss are essential given the stock's micro-cap status.

What are the biggest risks for MJRX.CN stock investors?

Major risks include negative earnings (EPS -0.14), very low current ratio (0.01), negative book value, thin liquidity, and reliance on project updates or financing to drive fundamentals. These increase volatility and downside risk.

CA Stocks

MJRX.CN Global Health Clinics (CNQ) up 57% on 12 Feb 2026: key catalyst ahead

ByDanny Kontos February 13, 2026

The MJRX.CN stock surged 57.14% to CAD 0.055 during market hours on 12 Feb 2026, driven by thin volume and a short-term rebound from its 50-day average. The move marks a sharp intraday reversal from a previous close of CAD 0.035 and lifted trading to 5,000 shares, almost double the average volume of 2,648. Investors should note this is small-cap, Canada-listed Global Health Clinics Ltd. (CNQ), a healthcare company focused on medical cannabis clinics and psilocybin development, where headline gains can reflect liquidity swings rather than sustained fundamental change.